Filter
3374
Filtered Results: 3374
Text search:
national
drug
authority
Featured
Recommendations
310
New Publications
978
Language
Document type
No document type
2039
Studies & Reports
516
Guidelines
437
Manuals
160
Strategic & Response Plan
124
Fact sheets
33
Training Material
32
Situation Updates
19
Infographics
5
Resource Platforms
4
Online Courses
3
Brochures
2
Countries / Regions
India
174
Global
108
Kenya
102
Ethiopia
96
Uganda
94
Western and Central Europe
89
Nigeria
67
Liberia
66
South Africa
65
Ghana
62
Sierra Leone
55
Tanzania
55
Latin America and the Carribbean
51
Myanmar / Burma
51
Nepal
50
Zambia
50
Malawi
49
Bangladesh
48
Africa
43
Rwanda
41
Eastern Europe
36
Ukraine
35
Zimbabwe
31
Cambodia
31
South–East Asia Region
29
Namibia
29
Asia
28
Philippines
26
Lesotho
22
Congo, Democratic Republic of
19
Botswana
18
Syria
16
Indonesia
14
Eastern Europe and Central Asia
13
Senegal
12
Mozambique
12
South Sudan
12
Eswatini/ Swaziland
12
Venezuela
11
Burkina Faso
10
East and Southern Africa
10
Russia
10
Haiti
9
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Brazil
9
Colombia
8
Albania
8
Guinea
8
Vietnam
8
Pakistan
8
Laos
7
USA
7
Tajikistan
6
Thailand
6
China
6
Cameroon
6
Afghanistan
6
Western Pacific Region
6
Georgia
6
Moldova
5
Sri Lanka
5
Sudan
5
Central African Republic
5
North Macedonia
4
Mexico
4
Jordan
4
Yemen
4
Iraq
4
Turkey
3
Benin
3
Iran
3
Fiji
3
Jamaica
3
Lebanon
3
Papua New Guinea
3
Palestine
3
Mali
3
Libya
3
Somalia
3
Timor Leste/ East Timor
2
El Salvador
2
Serbia
2
Chile
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Mongolia
2
Armenia
2
Hungary
2
Saudi Arabia
2
North America
2
United Kingdom
2
Portugal
2
Southern Africa
2
Bolivia
2
Argentina
2
Poland
2
Bhutan
2
North Korea
1
Switzerland
1
Australia
1
Kazakhstan
1
Canada
1
Estonia
1
Qatar
1
Bulgaria
1
Italy
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1278
Clinical Guidelines
329
Public Health
195
Women & Child Health
145
Key Resources
90
Pharmacy & Technologies
56
Capacity Building
49
Toolboxes
HIV
361
TB
312
Mental Health
281
AMR
205
COVID-19
149
Pharmacy
141
NTDs
99
Rapid Response
79
Caregiver
65
Ebola
58
Planetary Health
51
Refugee
49
NCDs
49
Conflict
45
Global Health Education
39
Disability
33
Polio
17
Zika
16
Natural Hazards
15
Specific Hazards
14
Cholera
14
Health Financing Toolbox
14
Social Ethics
5
Health Financing
1
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with a checklist tool to ensure that key areas have been covered. An excel version that local authorities m...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it t...
The One Health approach can help achieve progress and promotes synergies on national and global priorities by generating synergies at the human-animal-environmental interface. While evidence is still scare, it is likely that the approach is highly cost-effective and improves effectiveness of core pu...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
The curriculum, which complements the national pediatric ART training, was finalized in 2011 and was subsequently implemented nationally. The training curriculum includes a 15-module Trainer Manual, a Participant Manual, and accompanying PowerPoint slides.
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na...
